Biofourmis Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 393

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 2

Biofourmis General Information

Description

Developer of a predictive health analytics platform designed to analyze physiology data from clinical-grade wearables. The company's platform uses artificial intelligence to integrate and analyze continuous physiology data from clinical-grade wearables to detect personalized patterns and predict clinical exacerbation in advance of a critical event, enabling medical professionals to intervene days before a critical event and providing better outcomes for patients.

Contact Information

Website
www.biofourmis.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 33 Arch Street
  • 18th Floor
  • Boston, MA 02110
  • United States
+1 (617)
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Parent Company
CopilotIQ
Vertical(s)
Digital Health, Wearables & Quantified Self, Artificial Intelligence & Machine Learning
Corporate Office
  • 33 Arch Street
  • 18th Floor
  • Boston, MA 02110
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biofourmis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 17-Sep-2024 Completed Generating Revenue
7. Later Stage VC (Series D) 27-Jul-2022 Completed Generating Revenue
6. Later Stage VC (Series C) 03-Sep-2020 Completed Generating Revenue
5. Debt - PPP 01-May-2020 Completed Generating Revenue
4. Early Stage VC (Series B) 21-May-2019 Completed Generating Revenue
3. Early Stage VC (Series A) 12-Dec-2017 Completed Generating Revenue
2. Early Stage VC $4M $5M Completed Generating Revenue
1. Angel (individual) 10-Aug-2016 $1M $1M Completed Generating Revenue
To view Biofourmis’s complete valuation and funding history, request access »

Biofourmis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a predictive health analytics platform designed to analyze physiology data from clinical-grade wearables. T
Decision/Risk Analysis
Boston, MA
393 As of 2024

Larkspur, CA
 

Eveleigh, Australia
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biofourmis Competitors (50)

One of Biofourmis’s 50 competitors is Caresyntax, a Venture Capital-Backed company based in Larkspur, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Caresyntax Venture Capital-Backed Larkspur, CA
Prospection Venture Capital-Backed Eveleigh, Australia
Perimatics Corporate Backed or Acquired Bellevue, WA
Welltory Venture Capital-Backed Redwood City, CA
LifeBEAM Formerly VC-backed New York, NY
You’re viewing 5 of 50 competitors. Get the full list »

Biofourmis Patents

  • 39

    Total Documents Applications and Grants

  • Total Patents Families

  • 20

    Granted

  • Pending

  • Expiring in next 12 mo

Biofourmis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019210434-A1 Method and apparatus for determining the impact of behavior-influenced activities on the health level of a user Inactive 02-May-2018
WO-2017079850-A1 Device having an optically sensitive input element Inactive 13-Nov-2015
EP-2768391-B1 Method for noninvasive optical measurements of physiological properties in tissue Active 19-Oct-2011
EP-2768391-A1 System for noninvasive optical measurements of physiological properties in tissue Active 19-Oct-2011
WO-2013056379-A1 System for noninvasive optical measurements of physiological properties in tissue Inactive 19-Oct-2011 A61B5/0295
To view Biofourmis’s complete patent history, request access »

Biofourmis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biofourmis Former Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
2050 Capital Venture Capital Minority
Ark Jianke Group Corporation Minority
Aviva Ventures Corporate Venture Capital Minority
CVS Health Ventures Corporate Venture Capital Minority
EDBI Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Biofourmis Acquisitions (3)

Biofourmis’s most recent deal was a Merger/Acquisition with Gaido (Healthcare). The deal was made on 16-Apr-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Gaido (Healthcare) 16-Apr-2020 Merger/Acquisition Decision/Risk Analysis
Biovotion 19-Nov-2019 Merger/Acquisition Monitoring Equipment
Hashtaag 01-Oct-2019 Merger/Acquisition Software Development Applications
To view Biofourmis’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Biofourmis FAQs

  • When was Biofourmis founded?

    Biofourmis was founded in 2015.

  • Where is Biofourmis headquartered?

    Biofourmis is headquartered in Boston, MA.

  • What is the size of Biofourmis?

    Biofourmis has 393 total employees.

  • What industry is Biofourmis in?

    Biofourmis’s primary industry is Decision/Risk Analysis.

  • Is Biofourmis a private or public company?

    Biofourmis is a Private company.

  • What is Biofourmis’s current revenue?

    The current revenue for Biofourmis is .

  • How much funding has Biofourmis raised over time?

    Biofourmis has raised $465M.

  • Who are Biofourmis’s investors?

    2050 Capital, Ark Jianke Group, Aviva Ventures, CVS Health Ventures, and EDBI are 5 of 15 investors who have invested in Biofourmis.

  • Who are Biofourmis’s competitors?

    Caresyntax, Prospection, Perimatics, Welltory, and LifeBEAM are some of the 50 competitors of Biofourmis.

  • When was Biofourmis acquired?

    Biofourmis was acquired on 17-Sep-2024.

  • Who acquired Biofourmis?

    Biofourmis was acquired by CopilotIQ.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process